Quick Answer
Pulmatrix, Inc. reported Total Revenue of $7.81 million for fiscal year 2024.
Pulmatrix, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | $7.81M +7.0% |
$7.30M +20.2% |
$6.07M +17.5% |
$5.17M -59.1% |
$12.63M +59.7% |
| Revenue (ASC 606) | — | $7.81M +7.0% |
$7.30M +20.2% |
$6.07M +17.5% |
$5.17M -59.1% |
$12.63M +59.7% |
| Net Income | -$5.16M +46.0% |
-$9.56M +32.3% |
-$14.12M +25.0% |
-$18.84M +6.6% |
-$20.17M -4.5% |
-$19.31M +6.3% |
| Diluted EPS | -$1.41 +46.2% |
-$2.62 +32.3% |
-$3.87 +29.1% |
-$5.46 | — | — |
| Total Assets | $4.14M -58.4% |
$9.94M -70.7% |
$33.96M -17.1% |
$40.95M -30.4% |
$58.82M +54.4% |
$38.09M +5.5% |
| Cash and Equivalents | $4.09M -57.1% |
$9.52M -50.3% |
$19.17M -46.2% |
$35.63M -33.8% |
$53.84M +70.1% |
$31.66M +35.1% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $3.81M -57.4% |
$8.95M -50.3% |
$18.00M -42.2% |
$31.11M -34.4% |
$47.45M +105.1% |
$23.14M +110.0% |
| R&D Expense | $38.0K -99.5% |
$7.17M -53.8% |
$15.52M -14.9% |
$18.24M +18.6% |
$15.38M -1.5% |
$15.61M +21.5% |
| Operating Income | -$5.17M +47.1% |
-$9.76M +33.8% |
-$14.74M +22.2% |
-$18.95M +6.0% |
-$20.17M -104.5% |
-$9.86M +52.3% |
| Shares Outstanding | 3.65M +0.0% |
3.65M +0.0% |
3.65M +0.4% |
3.64M +12.9% |
3.22M +78.5% |
1.81M +18052400.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2024 | $366.0K | -79.1% | -76.4% |
| Revenue (ASC 606) | September 30, 2024 | $366.0K | -79.1% | -76.4% |
| Net Income | September 30, 2025 | -$877.0K | +66.1% | +43.4% |
| Diluted EPS | September 30, 2025 | -$0.24 | +66.2% | +42.9% |
| Total Assets | September 30, 2025 | $4.98M | -56.7% | -19.0% |
| Cash and Equivalents | September 30, 2025 | $4.79M | -55.5% | -17.7% |
| Long-Term Debt | June 30, 2017 | $1.80M | -60.3% | -28.5% |
| Stockholders Equity | September 30, 2025 | $4.73M | -56.7% | -15.5% |
| R&D Expense | September 30, 2025 | $8.0K | -99.0% | -42.9% |
| Operating Income | September 30, 2025 | -$866.0K | +67.4% | +44.1% |
| Shares Outstanding | September 30, 2025 | 3.65M | +0.0% | +0.0% |
- Pulmatrix, Inc. reported Total Revenue of $7.81 million for fiscal year 2024.
- Pulmatrix, Inc. showed an increase of +7.0% in Total Revenue compared to the prior fiscal year.
- Pulmatrix, Inc. reported Revenue (ASC 606) of $7.81 million for fiscal year 2024.
- Pulmatrix, Inc. showed an increase of +7.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Pulmatrix, Inc. reported Net Income of -$5.16 million for fiscal year 2025.
- Pulmatrix, Inc. showed an increase of +46.0% in Net Income compared to the prior fiscal year.
- Pulmatrix, Inc. reported Diluted EPS of $1.41 per share (loss) for fiscal year 2025.
- Pulmatrix, Inc. showed an increase of +46.2% in Diluted EPS compared to the prior fiscal year.
- Pulmatrix, Inc. reported Total Assets of $4.14 million for fiscal year 2025.
- Pulmatrix, Inc. showed a decrease of -58.4% in Total Assets compared to the prior fiscal year.
- Pulmatrix, Inc. reported Cash and Equivalents of $4.09 million for fiscal year 2025.
- Pulmatrix, Inc. showed a decrease of -57.1% in Cash and Equivalents compared to the prior fiscal year.
- Pulmatrix, Inc. reported Long-Term Debt of $3.22 million for fiscal year 2016.
- Pulmatrix, Inc. showed a decrease of -43.5% in Long-Term Debt compared to the prior fiscal year.
- Pulmatrix, Inc. reported Stockholders Equity of $3.81 million for fiscal year 2025.
- Pulmatrix, Inc. showed a decrease of -57.4% in Stockholders Equity compared to the prior fiscal year.
- Pulmatrix, Inc. reported R&D Expense of $38.0 thousand for fiscal year 2025.
- Pulmatrix, Inc. showed a decrease of -99.5% in R&D Expense compared to the prior fiscal year.
- Pulmatrix, Inc. reported Operating Income of -$5.17 million for fiscal year 2025.
- Pulmatrix, Inc. showed an increase of +47.1% in Operating Income compared to the prior fiscal year.
- Pulmatrix, Inc. reported Shares Outstanding of 3.65 million shares for fiscal year 2025.
- Pulmatrix, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: